Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00932373
What this trial is testing

Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 54
Not applicableStudy completedNCT02615054
What this trial is testing

Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors

Who this might be right for
Trastuzumab CardiotoxicityHER2-Positive Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)UnknownNCT04334330
What this trial is testing

Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China

Who this might be right for
Breast CancerBrain Metastases
Sun Yat-sen University 34
Testing effectiveness (Phase 2)Study completedNCT02673398
What this trial is testing

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Ended earlyNCT04578106
What this trial is testing

Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast CancerStage I Breast Cancer
Fundacio Clinic Barcelona 5
Early research (Phase 1)WithdrawnNCT01219907
What this trial is testing

Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage IV Breast Cancer
University of Washington
Testing effectiveness (Phase 2)Ended earlyNCT00674414
What this trial is testing

Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
UNICANCER 82
Large-scale testing (Phase 3)Study completedNCT05415215
What this trial is testing

Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

Who this might be right for
Early Breast CancerLocally Advanced Breast CancerInflammatory Breast Cancer
Hoffmann-La Roche 346
Testing effectiveness (Phase 2)Study completedNCT00148668
What this trial is testing

Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Eric Winer, MD 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)UnknownNCT04582968
What this trial is testing

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesHER2-positive Breast Cancer
Fudan University 39
Early research (Phase 1)Study completedNCT02073916
What this trial is testing

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Jenny C. Chang, MD 24
Not applicableLooking for participantsNCT07264985
What this trial is testing

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Who this might be right for
Breast CancerDrug-Related Side EffectsDiarrhea
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Testing effectiveness (Phase 2)UnknownNCT04236310
What this trial is testing

Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.

Who this might be right for
Breast CancerHER2-positive Breast CancerER-positive Breast Cancer
Ruijin Hospital 37
Not applicableStudy completedNCT05839288
What this trial is testing

Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Fudan University 161
Testing effectiveness (Phase 2)Study completedNCT00976989
What this trial is testing

Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 225
Testing effectiveness (Phase 2)Study completedNCT00129896
What this trial is testing

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 73
Not applicableWithdrawnNCT02616224
What this trial is testing

Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer, HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT02131064
What this trial is testing

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 444
Next Page